Slate Run Pharmaceuticals recalls

1 recalls.

• Eptifibatide Injection recall (Slate Run Pharmaceuticals)
  DrugClass IIIReported March 4, 2026 · Labeling: Not Elsewhere Classified. The carton for Eptifibatide Injection 75 mg/100 mL states 75 mg/100 mL vial for weight-adjusted bolus dosing. The approved...